Edition: India  
 
> >

Laurus Labs Demonstrates Strong Q3 Growth in the First Quarterly Results After Successful IPO

Business Wire India Monday, 13 February 2017
Laurus Labs Demonstrates Strong Q3 Growth in the First Quarterly Results After Successful IPO*Business Wire India*Laurus Labs Ltd. (Laurus), a leading research and development driven pharmaceutical company in India announces its 9M & Q3 FY17 results.   *9M FY17 results:*  

· Total Revenue grew by 9.7% to Rs.14,459 mn from Rs.13,179 mn
· EBITDA increased by 23.1% to Rs.3,199 mn versus Rs.2,598 mn
· PAT higher by 40.5% to Rs.1,277 mn from Rs.909 mn
· EPS (Diluted) for the period stood at Rs.12.9 per share (not annualised)

*Q3 FY17 results:*  

· Total Revenue grew by 12.3% to Rs.5,054 mn from Rs.4,501 mn
· EBITDA increased by 9.4% to Rs.1,115 mn versus Rs.1,019 mn
· PAT higher by 17.5% to Rs.472 mn from Rs.402 mn
· EPS (Diluted) for the period stood at Rs.4.7 per share (not annualised)

*Business Highlights – 9M FY17:*  

· Prepayment of long term loans of Rs.2,263 million from IPO proceeds, Rs.585 million spent on general corporate purposes after meeting IPO expenses of Rs.150 million.
· Capex investments in first nine months Rs.2,584 million.
· R & D opex investments Rs.773 million and 5.3% as percentage of sales during Apr – Dec, 2016
· In partnership with Laurus, Natco has launched Velpatasivir (Hep-C) product in Nepal and is geared up for launch in India upon approval.
· As on Dec 2016, the Company has filed 202 patent applications and 37 patents granted.
· Expansion of R & D centre at Hyderabad completed.
· As on date filed 2 ANDAs and in addition completed 4 product validations.
· Capacity expansion of 5 billion tablets is expected to complete by end Mar 17.
· US FDA and WHO inspection scheduled during March 2017 for Unit 2.
· FDF opex investments are Rs.821 million which includes Rs.253 million relating to the R& D during Apr – Dec, 2016
· Unit 5 (dedicated manufacturing facility for Aspen) is inaugurated and is operational in Nov ‘16
· Laurus signed manufacturing and supply agreement for Oncology NCE for clinical phase and commercial supplies
· Dr. Satyanarayana Chava nominated as one of the members of US pharmacopeia Board of Trustees (BoT)
· Laurus Labs received Pharmaexcil patent Silver Award for the contribution in the category of Bulk Drugs /APIs to India’s Pharmaceutical Exports during the year 2015-16

*For more information about us, please visit **http://www.lauruslabs.com**.*       View source version on businesswire.com: http://www.businesswire.com/news/home/20170209006030/en/
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Nets A/S: Financial results for Q2 2017

* Company announcement * No. 24/2017   * *Financial results for Q2 2017* * *Highlights for Q2 2017* · Solid organic growth in net revenue of 5%,...
GlobeNewswire - Press ReleasesAlso reported by •FinanzNachrichten.de

Hikma sounds the earnings alarm sending shares crashing

Shares in Hikma Pharmaceuticals (LON:HIK) were marked down 7% after the company lowered guidance for sales of generic products and warned of an “increasingly...
Proactive Investors - Business

A level results 2017: Landau Forte Academy Tamworth Sixth Form

A level results 2017: Landau Forte Academy Tamworth Sixth Form
STUDENTS at Tamworth's only sixth form are today celebrating a strong set of A Level results – with many of them off to their first choice universities. Pupils...
Tamworth Herald - UKAlso reported by •Lichfield MercuryBlackmore Vale

Second Quarter and Year-to-Date Operating Results Confirm PotNetwork Holding’s Revenues Maintain Strong, on Target Performance, and Continue to Exceed Fiscal 2017 Forecasts

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--PotNetwork Holding, Inc. (OTC Pink: POTN) is pleased to announce that based on earlier reported filed financial...
Business Wire - Press Releases

RSI International Systems says becoming operating free cash flow positive remains a priority

Toronto-listed RSI International Systems Inc (CVE:RSY) highlighted the progress it's made in its goal to become operating cash flow positive in the light of its...
Proactive Investors - Business


You Might Like


Other recent news in Press Releases

373 UNC Health Care Physicians Named to 2017-2018 Best Doctors in AMERICA® ListCiti and Presidents Cup Announce the Citi 44 Million Yard CHALLENGE
Spirent Tests Wi-Fi Network Performance with O2 at the Coca-Cola LONDON EyeTRAVEL Tech Startup TRAVELSPICE Expands Use of Microsoft Azure
NINTENDO SWITCH Splatoon 2 Edition Bundle Heads Exclusively to Walmart StoresESSENTIAL PHONE Pre-Order Begins Today from Sprint, Exclusive Retail Carrier
SPECTRUM Pharmaceuticals to Present Corporate Update at the 2017 Southern California Investor Conference in Newport Beach on Thursday, August 24thFederal Reserve Bank of Dallas President to Speak on the Economic Climate, and Its IMPACT on Monetary Policy, Sept. 5
Kinross Gold, Trout Unlimited and Rocky Mountain Elk Foundation partner to protect wildlife habitat near YELLOWSTONE NATIONAL PARKBusiness News Daily Ranks InfoMart Among Best BACKGROUND CHECK Services

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter